Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
29.10
-0.20 (-0.68%)
Jun 27, 2025, 5:04 PM CET
-56.89%
Market Cap 534.14M
Revenue (ttm) 359.79M
Net Income (ttm) -4.95M
Shares Out 18.36M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE 21.13
Dividend n/a
Ex-Dividend Date n/a
Volume 42,203
Average Volume 45,561
Open 29.10
Previous Close 29.30
Day's Range 29.00 - 29.60
52-Week Range 26.50 - 69.90
Beta 0.01
RSI 44.94
Earnings Date Sep 12, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.